Astria Therapeutics to Present at Upcoming Jefferies Healthc

Astria Therapeutics, Inc. , a biopharmaceutical company developing STAR-0215 for hereditary angioedema and focused on life-changing therapies for rare and niche allergic and immunological diseases,... | May 31, 2023

Related Keywords

New York , United States , Jillc Milne , , Nasdaq , Astria Therapeutics Inc , Astria Therapeutics , Chief Executive Officer , Jefferies Healthcare Conference , Nc Stock Exchange , News , Information , Press Release , Austria , Iopharmaceutical , Company , Developing , Or , Hereditary , Angioedema , End , Ocused , N , Therapies , Mare , Niche , Aallergic , Mmunological Atxs Us04635x1028 ,